Walpar Nutritions Limited (NSE:WALPAR)
India · Delayed Price · Currency is INR 25.00
-1.10 (-4.21%)
At close: Oct 28, 2026
Walpar Nutritions Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 832.15 | 787.9 | 717.63 | 625.22 | 351.42 | 267.57 |
Other Revenue | 3.98 | 1.24 | 1.97 | 0.91 | 2.13 | 0.17 |
| 836.13 | 789.14 | 719.6 | 626.13 | 353.55 | 267.74 | |
Revenue Growth | 10.39% | 9.66% | 14.93% | 77.10% | 32.05% | 47.07% |
Cost of Revenue | 617.56 | 595.83 | 567.14 | 498.6 | 241.5 | 210.56 |
Gross Profit | 218.56 | 193.31 | 152.46 | 127.53 | 112.05 | 57.18 |
Selling, General & Admin | 97.22 | 91.95 | 64.16 | 53.63 | 53.05 | 35.02 |
Other Operating Expenses | 37.49 | 32.59 | 28.7 | 24.89 | 20.56 | 11.57 |
Operating Expenses | 157.79 | 144.72 | 111.05 | 96.62 | 92.71 | 49.42 |
Operating Income | 60.77 | 48.59 | 41.41 | 30.91 | 19.34 | 7.76 |
Interest Expense | -9.36 | -6.29 | -2.44 | -6.34 | -7.57 | -4.44 |
Interest & Investment Income | 0.05 | 0.05 | 0.01 | 0.01 | 0.07 | 0.1 |
Earnings From Equity Investments | -3.38 | -2.04 | - | - | - | - |
Currency Exchange Gain (Loss) | 0.25 | 0.25 | 0.25 | 0.08 | -0.2 | -0.14 |
Other Non Operating Income (Expenses) | -1.58 | -1.58 | -0.45 | -0.35 | -0.37 | -0.4 |
EBT Excluding Unusual Items | 46.76 | 38.99 | 38.78 | 24.31 | 11.28 | 2.89 |
Gain (Loss) on Sale of Investments | - | - | - | 0.5 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.13 | - | - |
Other Unusual Items | - | - | - | - | -0.16 | -0.15 |
Pretax Income | 46.76 | 38.99 | 38.78 | 24.93 | 11.11 | 2.73 |
Income Tax Expense | 14.35 | 8.96 | 10.8 | 5.48 | 3.02 | -0.83 |
Earnings From Continuing Operations | 32.41 | 30.03 | 27.98 | 19.46 | 8.1 | 3.56 |
Minority Interest in Earnings | -8.16 | -5.29 | -4.74 | -3.64 | -2.2 | 0.25 |
Net Income | 24.25 | 24.74 | 23.24 | 15.82 | 5.9 | 3.81 |
Net Income to Common | 24.25 | 24.74 | 23.24 | 15.82 | 5.9 | 3.81 |
Net Income Growth | 4.02% | 6.45% | 46.92% | 168.11% | 55.00% | -15.51% |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 8 | 8 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 8 | 8 |
Shares Change | -0.00% | - | 0.25% | 11.19% | - | 30.36% |
EPS (Basic) | 2.59 | 2.64 | 2.48 | 1.69 | 0.70 | 0.45 |
EPS (Diluted) | 2.59 | 2.64 | 2.48 | 1.69 | 0.70 | 0.45 |
EPS Growth | 4.02% | 6.45% | 46.56% | 141.12% | 55.00% | -34.50% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -40.82 | -17.57 | 17.76 | 34.79 | -41.43 | -49.28 |
Free Cash Flow Per Share | -4.35 | -1.87 | 1.89 | 3.71 | -4.92 | -5.85 |
Gross Margin | 26.14% | 24.50% | 21.19% | 20.37% | 31.69% | 21.36% |
Operating Margin | 7.27% | 6.16% | 5.75% | 4.94% | 5.47% | 2.90% |
Profit Margin | 2.90% | 3.14% | 3.23% | 2.53% | 1.67% | 1.42% |
Free Cash Flow Margin | -4.88% | -2.23% | 2.47% | 5.56% | -11.72% | -18.41% |
EBITDA | 83.63 | 68.54 | 59.6 | 49 | 38.44 | 10.59 |
EBITDA Margin | 10.00% | 8.69% | 8.28% | 7.83% | 10.87% | 3.95% |
D&A For EBITDA | 22.85 | 19.94 | 18.19 | 18.1 | 19.1 | 2.83 |
EBIT | 60.77 | 48.59 | 41.41 | 30.91 | 19.34 | 7.76 |
EBIT Margin | 7.27% | 6.16% | 5.75% | 4.94% | 5.47% | 2.90% |
Effective Tax Rate | 30.68% | 22.98% | 27.84% | 21.97% | 27.14% | - |
Revenue as Reported | 837.49 | 790.5 | 720.29 | 627.4 | 354.77 | 268.02 |